n/a
Pilotto S., Bria E., Peretti U., Massari F., Garassino M., Pelosi G., et al. (2013). Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number. JOURNAL OF THORACIC ONCOLOGY, 8(12), 105-106 [10.1097/JTO.0b013e3182a00e37].
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number
Massari F.;
2013
Abstract
n/aFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
